AI Coming for Pharmacy Benefit Managers: Winners and Losers
Artificial intelligence is accelerating the disruption of pharmacy benefit managers, reshaping margins and creating n...
This section highlights volatility metrics for the dividend aristocrats ETF, offering key indicators to monitor risk and potential entry points.
22,062 articlesArtificial intelligence is accelerating the disruption of pharmacy benefit managers, reshaping margins and creating n...
A new Milken-Harris poll shows 80% of Americans want government-backed AI workforce programs now, with 68% feeling th...
Investors are watching a pivotal Starship test as markets gauge the odds of a SpaceX IPO. A successful launch could s...
A revived SpaceX IPO talk targets a multi‑trillion valuation, potentially lifting Elon Musk over $1 trillion in net w...
Greg Abel, Warren Buffett's successor, steered a careful set of portfolio moves in the first quarter. This article br...
Missed inquiries are quietly eroding real estate commissions as buyers and sellers move quickly to rivals. A new stud...
Small-cap stocks have shown strength this year, but Wells Fargo argues the rally masks deteriorating earnings trends ...
Investors are watching Ambarella’s path to 2027 with a focus on growth drivers, margins, and the long-term AI camera ...
The Caesars deal upends the regional gaming scene and shifts attention to which casino stocks could be the next buyou...
Credo Technology faces a pivotal Q4 print as analysts and traders dissect margins, inventory builds, and AI demand si...
Gitcha joins Momentum MLS in a strategic move to embed a Buyer Listing Service, turning the western Arizona platform ...
A veteran market strategist warns that investors are chasing tech as a safe haven. He expects a broad rotation into h...